Russia to supply 100 million doses of Sputnik V vaccine to Dr Reddy's

Credit: Mid-Day- Published on September 16, 2020
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited, a global pharmaceutical company headquartered in India, have agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India, Russia's sovereign wealth fund revealed in a statement on Wednesday.

Sputnik V, an...

Video credit: Oneindia
Published on September 16, 2020 -  01:03
Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News
Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's sovereign wealth fund. Upon regulatory approval in India, the RDIF shall supply to Dr Reddy’s 100 million doses of the vaccine. The Sputnik V vaccine, which is based on human adenoviral vector platform, is undergoing clinical trials. Deliveries could potentially begin in late 2020, subject to completion of successful trials and registration of the vaccine by regulatory authorities in India. The RDIF said its partners will receive an effective and safe drug to fight the novel coronavirus.

You are here

Related videos from verified sources

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines 05:47
Credit: HT Digital Content - Published 1 week ago 

Covid-19: India declines proposal to test Sputnik-V Covid-19 vaccine in a large study |Oneindia News 01:16
Credit: Oneindia - Published 2 weeks ago 

The scientist behind Russia's 'Sputnik' vaccine 02:16
Credit: Reuters Studio - Published on September 29, 2020 

Related news from verified sources

You might like